Bicara Therapeutics (BCAX) Stock Chart & Stock Price History $22.25 +0.25 (+1.14%) (As of 04:14 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Bicara Therapeutics Stock Price Performance5 Day Performance-6.59%1 Month Performance+11.42% Receive BCAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. BCAX Stock Chart for Thursday, November, 14, 2024 BCAX Chart by TradingView Bicara Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/13/2024$22.35$22.00-1.57%$23.17$21.82268,955 shs$1.14 billion11/12/2024$24.11$22.35-7.30%$24.15$22.10238,795 shs$1.16 billion11/11/2024$23.82$24.11+1.22%$24.58$23.36148,530 shs$1.25 billion11/08/2024$23.60$23.82+0.93%$24.70$23.16178,233 shs$1.23 billion11/07/2024$23.77$23.60-0.72%$25.09$23.27193,351 shs$1.22 billion11/06/2024$25.19$23.77-5.64%$28.09$23.67371,258 shs$1.23 billion Get the Latest News and Ratings for BCAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/05/2024$24.97$25.19+0.88%$26.00$24.31487,895 shs$1.30 billion11/04/2024$24.01$24.97+4.00%$25.36$23.30388,784 shs$1.29 billion11/01/2024$23.68$24.01+1.39%$24.89$23.44306,783 shs$1.24 billion10/31/2024$23.70$23.68-0.08%$24.22$22.55309,780 shs$1.23 billion10/30/2024$23.64$23.70+0.25%$24.83$23.17279,542 shs$1.23 billion10/29/2024$22.35$23.64+5.77%$23.93$21.80308,239 shs$1.22 billion10/28/2024$22.50$22.35-0.67%$23.40$22.35282,499 shs$1.16 billion10/25/2024$22.61$22.50-0.49%$23.35$22.25133,699 shs$1.16 billion10/24/2024$22.48$22.61+0.58%$23.36$22.03186,939 shs$1.17 billion10/23/2024$22.66$22.48-0.79%$22.85$22.00108,270 shs$1.16 billion10/22/2024$22.48$22.66+0.80%$23.53$22.48268,699 shs$1.17 billion10/21/2024$21.96$22.48+2.37%$23.00$21.55402,431 shs$1.16 billion10/18/2024$20.44$21.96+7.44%$22.85$20.24588,833 shs$1.14 billion10/17/2024$20.20$20.44+1.19%$20.99$19.99509,068 shs$1.06 billion10/16/2024$20.00$20.20+1.00%$20.52$19.75226,888 shs$1.05 billion10/15/2024$19.97$20.00+0.15%$20.88$19.59677,530 shs$1.04 billion10/14/2024$19.41$19.97+2.89%$21.10$19.07409,749 shs$1.03 billion10/11/2024$19.00$19.41+2.16%$20.00$18.33614,560 shs$1.00 billion10/10/2024$20.30$19.00-6.40%$20.66$18.58844,922 shs$983.44 million10/09/2024$22.55$20.30-9.98%$23.33$20.11469,479 shs$1.05 billion10/08/2024$24.45$22.55-7.77%$24.96$22.00421,614 shs$1.17 billion10/07/2024$25.16$24.45-2.82%$25.75$24.1769,721 shs$1.27 billion10/04/2024$23.80$25.16+5.71%$25.38$23.10203,306 shs$1.30 billion10/03/2024$23.20$23.80+2.59%$24.86$22.79405,016 shs$1.23 billion10/02/2024$24.43$23.20-5.03%$24.94$22.70336,473 shs$1.20 billion10/01/2024$25.47$24.43-4.08%$25.68$23.61615,088 shs$1.26 billion09/30/2024$25.44$25.47+0.12%$25.68$23.75189,068 shs$1.32 billion09/27/2024$25.70$25.44-1.01%$27.45$24.80217,250 shs$1.32 billion09/26/2024$26.30$25.70-2.28%$26.70$24.65224,905 shs$1.33 billion09/25/2024$25.75$26.30+2.14%$26.89$24.97186,679 shs$1.36 billion09/24/2024$25.53$25.75+0.86%$25.85$24.7670,667 shs$0.0009/23/2024$25.61$25.53-0.31%$26.68$24.55163,060 shs$0.0009/20/2024$24.60$25.61+4.11%$26.50$22.12620,288 shs$0.0009/19/2024$25.73$24.60-4.39%$26.45$24.101.03 million shs$0.00Elon Musk has put himself in their crosshairs (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary.09/18/2024$27.07$25.73-4.95%$27.47$24.80299,459 shs$0.0009/17/2024$25.41$27.07+6.53%$27.94$24.06421,300 shs$0.0009/16/2024N/A$25.41$27.70$22.34786,358 shs$0.00 Related Companies CRNX Stock Chart RARE Stock Chart IMVT Stock Chart TGTX Stock Chart RYTM Stock Chart OGN Stock Chart IBRX Stock Chart APLS Stock Chart MRUS Stock Chart BHC Stock Chart Receive BCAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCAX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
